Description:Mometasone furoate monohydrate is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties, primarily used in the treatment of various allergic and inflammatory conditions, including asthma and rhinitis. It is characterized by its high potency and low systemic bioavailability, which minimizes potential side effects associated with corticosteroids. The substance appears as a white to off-white crystalline powder and is soluble in organic solvents like ethanol and dimethyl sulfoxide, but has limited solubility in water. Its molecular structure includes a furoate ester, contributing to its pharmacological activity. Mometasone furoate monohydrate is often formulated in topical preparations, nasal sprays, and inhalers, allowing for targeted delivery to affected tissues. The compound's stability and efficacy make it a valuable option in clinical settings, although it is essential to use it under medical supervision to avoid potential side effects, particularly with long-term use.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
![Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, hydr…](https://static.cymitquimica.com/products/IN/thumb/DA001GU1.jpg)
